These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7590898)

  • 1. Increased level of activated gamma delta lymphocytes correlates with disease severity in HIV infection.
    Norazmi MN; Arifin H; Jamaruddin MA
    Immunol Cell Biol; 1995 Jun; 73(3):245-8. PubMed ID: 7590898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
    Benito JM; Zabay JM; Gil J; Bermejo M; Escudero A; Sánchez E; Fernández-Cruz E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):128-35. PubMed ID: 9052721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
    AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarity of expression of activation markers and CD28 on gamma delta and alpha beta-receptor T cells in HIV infection.
    Jouen-Beades F; Gilbert D; Ramzaoui S; Borsa-Lebas F; Humbert G; Tron F
    Clin Immunol Immunopathol; 1996 May; 79(2):189-93. PubMed ID: 8620625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
    Vanham G; Kestens L; De Meester I; Vingerhoets J; Penne G; Vanhoof G; Scharpé S; Heyligen H; Bosmans E; Ceuppens JL
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):749-57. PubMed ID: 8099610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection.
    Prince HE; Jensen ER
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1227-32. PubMed ID: 1719188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cell subsets in aging.
    Ruiz M; Esparza B; Pérez C; Barranquero M; Sabino E; Merino F
    Immunol Invest; 1995 Nov; 24(6):891-5. PubMed ID: 8575835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
    Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
    J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
    AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
    Echaniz P; Arrizabalaga J; Iribarren JA; Cuadrado E
    Cell Immunol; 1993 Aug; 150(1):72-80. PubMed ID: 7688270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.
    Rodrigues DS; Medeiros EA; Weckx LY; Bonnez W; Salomão R; Kallas EG
    Clin Exp Immunol; 2002 Apr; 128(1):149-54. PubMed ID: 11982602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA
    AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.
    Plaeger-Marshall S; Hultin P; Bertolli J; O'Rourke S; Kobayashi R; Kobayashi AL; Giorgi JV; Bryson Y; Stiehm ER
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):984-93. PubMed ID: 7688045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
    Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
    J Immunol; 1999 Sep; 163(6):3539-48. PubMed ID: 10477629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.